Drugs Information:
Regadenoson
Basic Information
|
|
||
| ID | DDInter1575 | |
| Drug Type | small molecule | |
| Molecular Formula | C15H18N8O5 | |
| Molecular Weight | 390.354 | |
| CAS Number | 313348-27-5 | |
| Description | Regadenoson is an A2A adenosine receptor agonist that causes coronary vasodilation and used for myocardial perfusion imagining. Manufactured by Astellas and FDA approved April 10, 2008. | |
| ATC Classification | C01EB21 | |
| IUPAC Name | 1-{6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-2-yl}-N-methyl-1H-pyrazole-4-carboxamide | |
| InChI | LZPZPHGJDAGEJZ-AKAIJSEGSA-N | |
| Canonical SMILES | CNC(=O)C1=CN(N=C1)C1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(N)=N1 | |
| Useful Links | DrugBank ChEBI PubChem Substance KEGG Drug ChemSpider BindingDB PharmGKB Wikipedia ChEMBL ZINC | |
Interactions with
Regadenoson
Filter:
| Severity level | ID | Name | Mechanism | Detail |
|---|
Interactions with diseases
Filter:
| Severity level | Disease name | Text | References |
|---|
Interactions with foods
Filter:
| Severity level | Food name | Description | Management | Mechanism | References |
|---|
Interactions with compound preparation
| Multi-DRUG trade | Multi-DRUG | Drug type | Warning | Note |
|---|